ATE414904T1 - Verfahren zum testen des oxidiertes-ldl-beta-2- glycoprotein-i-komplexes in vivo - Google Patents

Verfahren zum testen des oxidiertes-ldl-beta-2- glycoprotein-i-komplexes in vivo

Info

Publication number
ATE414904T1
ATE414904T1 AT03794267T AT03794267T ATE414904T1 AT E414904 T1 ATE414904 T1 AT E414904T1 AT 03794267 T AT03794267 T AT 03794267T AT 03794267 T AT03794267 T AT 03794267T AT E414904 T1 ATE414904 T1 AT E414904T1
Authority
AT
Austria
Prior art keywords
beta
complex
glycoprotein
vivo
testing
Prior art date
Application number
AT03794267T
Other languages
English (en)
Inventor
Eiji Matsuura
Original Assignee
Eiji Matsuura
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eiji Matsuura filed Critical Eiji Matsuura
Application granted granted Critical
Publication of ATE414904T1 publication Critical patent/ATE414904T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Endocrinology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT03794267T 2002-09-06 2003-09-05 Verfahren zum testen des oxidiertes-ldl-beta-2- glycoprotein-i-komplexes in vivo ATE414904T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002261366 2002-09-06

Publications (1)

Publication Number Publication Date
ATE414904T1 true ATE414904T1 (de) 2008-12-15

Family

ID=31973126

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03794267T ATE414904T1 (de) 2002-09-06 2003-09-05 Verfahren zum testen des oxidiertes-ldl-beta-2- glycoprotein-i-komplexes in vivo

Country Status (7)

Country Link
US (1) US7455976B2 (de)
EP (1) EP1548436B1 (de)
JP (1) JP4280236B2 (de)
AT (1) ATE414904T1 (de)
AU (1) AU2003261976A1 (de)
DE (1) DE60324820D1 (de)
WO (1) WO2004023141A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2728473A1 (en) 2008-06-20 2009-12-23 National University Corporation Okayama University Antibody against oxidized ldl/.beta.2gpi complex and use of the same
US8871459B2 (en) * 2009-08-07 2014-10-28 Astute Medical, Inc. Method for evaluating renal status by determining beta-2-glycoprotein 1
JP6399987B2 (ja) * 2015-09-11 2018-10-03 ヤマサ醤油株式会社 抗β２−ＧＰＩ抗体の測定法
US10858422B2 (en) 2016-05-31 2020-12-08 Abcentra, Llc Methods for treating systemic lupus erythematosus with an anti-apolipoprotein B antibody
WO2017210360A1 (en) 2016-05-31 2017-12-07 Cardiovax, Llc Methods for diagnosing and treating systemic lupus erythematosus
JP6826740B1 (ja) * 2020-02-06 2021-02-10 国立大学法人 岡山大学 酸化ＬＤＬ／β２ＧＰＩ複合体の検出方法、及び、検出キット

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07306202A (ja) 1992-04-01 1995-11-21 Maruzen Petrochem Co Ltd 細胞核ｄｎａの損傷検出方法
WO1995009363A1 (en) 1993-09-29 1995-04-06 Yamasa Corporation Method of assaying oxidized lipoprotein and application thereof

Also Published As

Publication number Publication date
EP1548436B1 (de) 2008-11-19
WO2004023141A1 (ja) 2004-03-18
JPWO2004023141A1 (ja) 2005-12-22
EP1548436A4 (de) 2006-09-20
US7455976B2 (en) 2008-11-25
DE60324820D1 (de) 2009-01-02
JP4280236B2 (ja) 2009-06-17
US20060099644A1 (en) 2006-05-11
AU2003261976A1 (en) 2004-03-29
EP1548436A1 (de) 2005-06-29

Similar Documents

Publication Publication Date Title
Weisman Erratum: ATS/ACCP statement on cardiopulmonary exercise testing
ATE433108T1 (de) Radiomarkierungssatz und bindungstest
CY1110116T1 (el) Νευροεκφυλιστικοι δεικτες για καταθλιψη
DE602005008848D1 (de) Verfahren und tragbarer Apparat zur Messung des Kalorieverbrauchs.
EP1732120A4 (de) Sondenvorrichtung, mit der sondenvorrichtung ausgestattete waferuntersuchungsvorrichtung und waferuntersuchungsverfahren
DE69430231D1 (de) Biosensor zum Messen der Alkoholkonzentration, Verfahren zur Herstellung des Biosensors, und den Biosensor benutzendes Betrunkenheitsmessgerät
ATE272377T1 (de) Bewertungsmethode für wegwerfbare absorbierende artikel
DK1067384T3 (da) Prøvedetektion for at igangsætte tidsmålingen i en elektrokemisk test
WO2005031005A3 (en) Compositions, methods and kits for determining the presence of trichomonas vaginalis in a test sample
WO2004094675A3 (en) Compositions and methods for determining the presence of sars coronavirus in a sample
DE602005020446D1 (de) Konfokale flüssigkeitsstandmessung
ATE443775T1 (de) Hif-prolylhydroxylase-aktivitätstest
EP1821099A4 (de) Ultraschalltestverfahrenund dafür verwendetes ultraschalltestgerät
WO2005124356A3 (en) Use of protein cbp2 as a marker for colorectal cancer
DE60324820D1 (de) Verfahren zum testen des oxidiertes-ldl-beta-2-glycoprotein-i-komplexes in vivo
ATE525656T1 (de) Proteinmessverfahren
ATE277352T1 (de) Einetenascin-c isoform als marker für neoplasmen
IL135884A (en) Method for measuring non-transferrin bound iron
DE50007635D1 (de) Verfahren zur diagnose von sjögren-syndrom
DE602005020874D1 (de) Frankiermaschine mit Verfahren und Anordnungen zur Vermeidung von Wiegefehlern bei Durchführung eines differentiellen Wägemodus
ATE540048T1 (de) Neurotransmittersensoren und verfahren zu ihrer verwendung
WO2006066917A3 (en) Use of asc as a marker for colorectal cancer
ATE482396T1 (de) Blockierter enzymsondenkomplex
DE50114111D1 (de) Elektrochemischer messfühler und verfahren zu dessen herstellung
AU2007332452B2 (en) Method for measuring 1,5-anhydroglucitol in whole blood, and sensor chip and measurement kit to be used in the method

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties